MOTS-c: Mitochondrial-Derived Peptide Research and AMPK Pathway Activation

Published July 20, 2026 · 7 min read · Research Use Only
Research Use Only Disclaimer This article is for educational and in-vitro research purposes only. MOTS-c is not approved by the FDA for any therapeutic use. Not intended for human or animal consumption. All biological effects described are from published peer-reviewed studies in controlled laboratory settings.

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. Discovered in 2015 by Dr. Changhan David Lee's laboratory at USC, MOTS-c represents a paradigm shift in our understanding of mitochondrial signaling. Unlike nuclear-encoded peptides, MOTS-c is transcribed from the 12S rRNA gene (MT-RNR1) in mitochondrial DNA, making it one of the first identified mitochondrial-derived peptides (MDPs) with signaling functions.

Molecular Properties

Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
PropertyValue
Molecular FormulaC101H152N28O22S2
Molecular Weight2174.58 g/mol
Amino Acid Count16 (hexadecapeptide)
OriginMitochondrial DNA (12S rRNA gene, MT-RNR1)
Net Charge at pH 7.4+3
Sequence (One-Letter)MRWQEMGYIFYPRKLR

AMPK Activation Mechanism

The primary studied mechanism of MOTS-c involves activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. Research has identified a multi-step signaling cascade:

  1. Folate cycle disruption: MOTS-c inhibits the folate cycle at the level of MTHFD2 (methylenetetrahydrofolate dehydrogenase 2), reducing de novo purine biosynthesis
  2. AICAR accumulation: Blocked purine synthesis causes accumulation of the intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a known endogenous AMPK activator
  3. AMPK phosphorylation: Accumulated AICAR activates AMPK through allosteric binding and promotion of Thr172 phosphorylation by upstream kinase LKB1
  4. Downstream effects: Activated AMPK increases glucose uptake (via GLUT4 translocation), fatty acid oxidation (via ACC phosphorylation), and mitochondrial biogenesis (via PGC-1alpha)

This mechanism is notable because MOTS-c does not directly bind AMPK. Instead, it activates AMPK indirectly through metabolic pathway modulation, making it functionally distinct from direct AMPK activators like metformin or AICAR itself.

Nuclear Translocation

A remarkable discovery published in 2020 demonstrated that MOTS-c translocates from the cytoplasm to the nucleus under metabolic stress conditions. In the nucleus, MOTS-c interacts with chromatin to regulate gene expression, particularly genes involved in the antioxidant response element (ARE) pathway. This nuclear function represents a direct communication channel from mitochondria to the nuclear genome, termed "retrograde signaling."

Exercise Mimetic Research

MOTS-c has been studied as a potential exercise mimetic due to several parallels between its effects and exercise-induced adaptations:

ParameterExercise EffectMOTS-c Effect (In Vivo Models)
AMPK activationIncreasedIncreased
Glucose uptakeEnhanced (GLUT4)Enhanced (GLUT4)
Fatty acid oxidationIncreasedIncreased via ACC inhibition
Mitochondrial biogenesisPGC-1alpha upregulationPGC-1alpha upregulation
Endogenous MOTS-c levelsIncreased in skeletal muscleN/A (exogenous)

Notably, circulating MOTS-c levels in humans have been shown to increase following acute exercise and decline with aging, suggesting a potential role as an endocrine mediator of exercise benefits.

Age-Related Decline

Endogenous MOTS-c levels decline with age across multiple species studied. In human cohorts, circulating MOTS-c is approximately 2-3x higher in young adults (20-30 years) compared to elderly subjects (65+ years). This decline correlates with reduced mitochondrial function and AMPK sensitivity observed in aging research models, positioning MOTS-c at the intersection of aging biology and metabolic research.

Research Handling Guidelines

MOTS-c contains two methionine residues (positions 1 and 6) susceptible to oxidation. For reproducible research results:

Research-Grade MOTS-c

99.8% HPLC-verified purity. Third-party tested. 10mg vial.

View MOTS-c Product

Further Reading

Notice All products sold by Peptide Spot are intended for laboratory research use only. They are not drugs, food, or cosmetics. Not intended for human or animal consumption. The buyer assumes all responsibility for compliance with applicable regulations.